Investment analysts at Deutsche Bank AG started coverage on shares of Novozymes A/S – (NASDAQ:NVZMY) in a research report issued to clients and investors on Friday. The firm set a “hold” rating on the stock.

A number of other equities research analysts have also commented on NVZMY. Zacks Investment Research lowered Novozymes A/S – from a “buy” rating to a “hold” rating in a research report on Wednesday, June 22nd. Berenberg Bank began coverage on Novozymes A/S – in a research report on Tuesday, September 27th. They set a “sell” rating for the company.

Novozymes A/S – (NASDAQ:NVZMY) opened at 44.04 on Friday. The company has a 50-day moving average price of $43.63 and a 200-day moving average price of $46.07. Novozymes A/S – has a 1-year low of $37.98 and a 1-year high of $49.55. The firm has a market cap of $13.23 billion and a P/E ratio of 30.65.

Novozymes A/S – Company Profile

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.

5 Day Chart for NASDAQ:NVZMY

Receive News & Stock Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related stocks with our FREE daily email newsletter.